Type of test Blood
Normal findings
RBCs
Type I (normal expression): 99%-100%
Type II (partial deficient): 0.00%-0.99%
Type III (deficient): 0.00%-0.01%
Granulocytes: 0.00%-0.01%
Monocytes: 0.00%-0.05%
Test explanation and related physiology
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematologic disorder characterized by nocturnal hemoglobinuria, chronic hemolytic anemia, thrombosis, pancytopenia, and, in some patients, acute or chronic myeloid malignancies. PNH appears to be a hematopoietic stem cell disorder that affects erythroid, granulocytic, and megakaryocytic cell lines. The abnormal cells in PNH have been shown to lack glycosylphosphatidylinositol (GPI)-linked proteins in RBCs and WBCs. Mutations in the phosphatidylinositol glycan A (PIGA) gene have been identified consistently in patients with PNH, thus confirming the biological defect in this disorder.
Flow cytometric immunophenotyping of peripheral blood (WBC and RBC) is performed to evaluate the presence or absence of PI-linked antigens (CD14, FLAER, and/or CD59 antigens), using monoclonal antibodies directed against them. These proteins are absent on the blood cells of patients with PNH. Determination of PI-linked antigens is not only useful in the diagnosis of PNH but also in monitoring of the disease.
Procedure and patient care
• See inside front cover for Routine Blood Testing.
• Fasting: no
• Blood tube commonly used: yellow
Abnormal findings
Decreased levels
- PNH